Skip to main content
. 2018 Jul 3;22(9):4068–4075. doi: 10.1111/jcmm.13679

Figure 1.

Figure 1

LncRNA FTH1P3 was up‐regulated in paclitaxel‐resistant breast cancer tissue and cells. A, RT‐PCR showed the lncRNA FTH1P3 expression level in 30 cases of breast cancer samples, including 15 cases of paclitaxel‐sensitive samples and 15 cases of paclitaxel‐resistant samples. B, RT‐PCR showed the lncRNA FTH1P3 expression levels in paclitaxel‐resistant breast cancer cell lines (MCF‐7/PTX, MDA‐MB‐231/PTX) and parental cell lines (MCF‐7, MDA‐MB‐231). C, FTH1P3 expression in MCF‐7 cells treated with different doses of paclitaxel. D, FTH1P3 expression in MDA‐MB‐231 cells treated with different doses of paclitaxel. Data were expressed as mean ± SD. *P < .05, **P < .01 represent statistically difference